Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: Results of a national survey

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 18, Issue 1, 2006, Pages 66-72

  Starace, F ^a   Wagner, T M ^b   Luzi, A M ^c   Cafaro, L ^a   Gallo, P ^c   Rezza, G ^c  

^a AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^b SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

CLINICAL TRIAL; HEALTH SURVEY; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; TELECONSULTATION; VOLUNTEER;

ADOLESCENT; ADULT; AIDS VACCINES; CLINICAL TRIALS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; ITALY; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 31544468708     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120500161777     Document Type: Review

References (34)

1. Autret, E., Dutertre, J.P., Barbier, P., et al. (1993). Parental opinions about biomedical research in children in Tours, France. Development in Pharmachological Therapy, 20, 64-71.
2. Barthelow, B.N., MacQueen, K.M., Doublas, J.M. Jr., et al. (1997). Assessment of the changing willingness to participate in Phase III HIV vaccine trials among men who have sex with men. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 16, 108-115.
3. Buchbinder, S.P., Metch, B., Holte, S.E., et al. (2004). Determinants of enrollment in a preventive HIV vaccine trial: Hypothetical versus actual willingness and barriers to participation. Journal of Acquired Immune Deficiency Syndrome, 36, 604-612.
4. Corbett, F., Oldham, J., & Lilford, R. (1996). Offering patients entry in clinical trials: Preliminary study of the views of prospective participants. Journal of Medical Ethics, 22, 227-231.
5. Celentano, D.D., Beyrer, C., Natpratan, C., et al. (1995). Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand. AIDS, 9, 1079-1083.
6. Donovan, J.L., & Blake, D.R. (1992). Patient non-compliance: Deviance or reasoned decision-making. Social Science and Medicine, 34(5), 507-513.
7. Ensoli, B., & Cafaro, A. (2000). Novel strategies toward the development of an effective vaccine to prevent human immunodeficiency virus infection or acquired immunodeficiency virus. AIDS Clinical Review, 01, 23-61.
8. Esparza, J., & Bhamarapravati, N. (2000). Accelerating the development and future availability of HIV-1 vaccines: Why, when, where and how? Lancet, 10, 2061-2066.
9. Fallowfield, L.J., Jenkins, V., Brennan, C., et al. (1998). Attitudes of patients to randomised clinical trials of cancer therapy. European Journal of Cancer, 34(10), 1554-1559.
10. Fisher, W.B., Cohen, S.J., Hammond, M.K., et al. (1991). Clinical trials in cancer therapy: Efforts to improve patient enrollment by community oncologists. Medical and Pediatric Oncology, 19, 165-168.
11. Gagnon, M.P., & Godin, G. (2000). Young adults and HIV vaccine: Determinants of the intention of getting immunized. Canadian Journal of Public Health, 91, 432-434.
12. Halpern, S.D., Metzger, D.S., Berlin, J.A., et al. (2001). Who will enroll? Predicting participation in a Phase II AIDS vaccine trial. Journal of Acquired Immune Deficiency Syndrome, 27, 281-288.
13. Henzlova, M.J., Blackburn, B.H., Bradley, E.J., et al. (1994). Patient perception of a long-term clinical trial: Experience using a close-out questionnaire in the Studies of Left Ventricular Dysfunction (SOLVD) trial. Controlled Clinical Trials, 15, 284-293.
14. Hoth, D.F., Bolognesi, D.P., Corey, L., et al. (1994). NIH conference. HIV vaccine development: A progress report. Annals of Internal Medicine, 121(8), 603-611.
15. Hunter, C.P., Frelick, R.W., Feldman, A.R., et al. (1987). Selection factors in clinical trials: Results from the Community Clinical Oncology Program Physician's Patient Log. Cancer Treatment Reports, 71, 559-565.
16. Jenkins, R.A., Chinaworapong, S., Morgan, P.A., et al. (1998). Motivation, recruitment and screening of volunteers for a Phase I/II HIV preventive vaccine trial in Thailand. Journal of Acquired Immune Deficiency Syndrome, 18(2), 171-177.
17. Jenkins, R.A., Temoshok, L.R., & Virochsiri, K. (1995). Incentives and disincentives to participate in prophylactic HIV vaccine research. Journal of Acquired Immune Deficiency Syndrome, 9, 36-42.
18. Jenkins, V., & Fallowfield, L. (2000). Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. British Journal of Cancer, 82(11), 1783-1788.
19. Kiwanuka, N., Robb, M., & Kigozi, G. (2004). Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: A population-based study, Rakai, Uganda. Journal of Acquired Immune Deficiency Syndrome, 36, 721-725.
20. Koblin, B.A., Heagerty, P., Sheon, A., et al. (1998). Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States. AIDS, 12, 785-793.
21. Koblin, B.A., Holte, S., Lenderking, B., et al. (2000). Readiness for HIV vaccine trials: Changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. Journal of Acquired Immune Deficiency Syndrome, 24(5), 451-457.
22. Liau, A., & Zimet, G.D. (2001). The acceptability of HIV immunization: Examining vaccine characteristics as determining factors. AIDS Care, 13, 643-650.
23. MacQueen, K.M., Buchbinder, S., Douglas, J.M., et al. (1994). The decision to enrol in HIV vaccine efficacy trials: Concerns elicited from gay men at increased risk for HIV infection. Journal of Acquired Immune Deficiency Syndrome, 10, 61-64.
24. MacQueen, K.M., Vanichseni, S., Kitayaporn, D., et al. (1999). Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand. Journal of Acquired Immune Deficiency Syndrome, 21(3), 243-251.
25. Maslin, A. (1994). A survey of the opinion on informed consent of women currently involved in clinical trials within a breast unit. European Journal of Cancer Care, 3, 153-162.
26. McGrath, J.W., George, K., Svilar, G., et al. (2001). Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military. Journal of Acquired Immune Deficiency Syndrome, 27(4), 381-388.
27. Orr, P.R., Blackhurst, D.W., & Hawkins, B.S. (1992). Patient and clinical factors predictive of missed visits and inactive status in a multi-center clinical trial. Controlled Clinical Trials, 13, 40-49.
28. Périssé, A.R.S., Schlechter, M., Moreira, R.I., et al. (2000). Willingness to participate in HIV trials among men who have sex with men in Rio de Janeiro, Brazil. Journal of Acquired Immune Deficiency Syndrome, 25, 459-463.
29. Ross, S., Grant, A., Counsell, C., et al. (1999). Barriers to participation in randomised controlled trials: A systematic review. Journal of Clinical Epidemiology, 52(12), 1143-1156.
30. Slevin, M., Mossman, J., Bowling, A., et al. (1995). Volunteers or victims: Patients' views of randomized cancer clinical trials. British Journal of Cancer, 71, 1270-1274.
31. Strauss, R.P., Sengupta, S., Kegeles, S., et al. (2001). Willingness to volunteer in future preventive HIV vaccines trials: Issues and perspectives from three US communities. Journal of Acquired Immune Deficiency Syndrome, 26, 63-71.
32. Taylor, K.M. (1985). The doctor's dilemma: Physician participation in randomised clinical trials. Cancer Treatment Reports, 69, 1095-1100.
33. Vlahov, D., Astemborski, J., Solomon, L., et al. (1994). Interest in HIV vaccines among injection drug users in Baltimore, Maryland. AIDS Research and Human Retroviruses, 10(Suppl. 2), S265-S268.
34. Zimet, G.D., Blythe, M.J., & Fortenberry, J.D. (2000). Vaccine characteristics and acceptability of HIV immunization among adolescents. International Journal of STD & AIDS, 1(3), 143-149.